Literature DB >> 17916378

Incidence of endophthalmitis after 20- and 25-gauge vitrectomy.

Derek Y Kunimoto1, Richard S Kaiser.   

Abstract

PURPOSE: To assess the incidence rate of endophthalmitis after 25-gauge pars plana vitrectomy and to compare it with the endophthalmitis rate after 20-gauge pars plana vitrectomy.
DESIGN: Retrospective, interventional, comparative cohort study. PARTICIPANTS: Eight thousand six hundred one consecutive pars plana vitrectomy surgery patients.
METHODS: Surgeries performed at a single institution between January 1, 2004, and September 1, 2006, were reviewed. MAIN OUTCOME MEASURES: Incidence of postvitrectomy endophthalmitis.
RESULTS: Endophthalmitis developed in 1 of 5498 eyes after 20-gauge vitrectomy (0.018%) and in 7 of 3103 eyes after 25-gauge vitrectomy cases (0.23%; P = 0.004). Median final visual acuity was counting fingers or hand movements (range, 20/50-no light perception), with comparable results between 20-gauge and 25-gauge endophthalmitis cases.
CONCLUSIONS: The visual outcomes of vitrectomy-associated endophthalmitis, for both 20-gauge and 25-gauge vitrectomy, is poor. In this study population, 25-gauge vitrectomy had a statistically significant 12-fold higher incidence of endophthalmitis compared with 20-gauge vitrectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17916378     DOI: 10.1016/j.ophtha.2007.08.009

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  62 in total

1.  Endophthalmitis following vitrectomy.

Authors:  J C Park; B Ramasamy; R H Ling; S Prasad
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy.

Authors:  Mahmoud Mohamed Farouk; Takeshi Naito; Khulood Mohammed Sayed; Toshihiko Nagasawa; Takashi Katome; Gamal Radwan; Ahmad Abdallah; Mohamed Elagouz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-17       Impact factor: 3.117

3.  Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy.

Authors:  Ingrid U Scott; Harry W Flynn; Nur Acar; Sundeep Dev; Saad Shaikh; Robert A Mittra; J Fernando Arevalo; Andres Kychenthal; Allen Kunselman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-18       Impact factor: 3.117

4.  25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases.

Authors:  Otman Sandali; Mohamed El Sanharawi; Nicolas Lecuen; Pierre-Olivier Barale; Sebastien Bonnel; Elena Basli; Vincent Borderie; Laurent Laroche; Claire Monin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-10       Impact factor: 3.117

5.  Incidence of post-operative endophthalmitis following 23-gauge transconjunctival sutureless vitrectomy in the United Kingdom: a survey.

Authors:  K C Patel; R Rahman
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

6.  Is It Time to Abandon Subconjunctival Antibiotics following Pars Plana Vitrectomy?

Authors:  John W Hinkle; Nidhi Relhan; Harry W Flynn
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

7.  Adverse events after pars plana vitrectomy among medicare beneficiaries.

Authors:  Joshua D Stein; David N Zacks; Daniel Grossman; Hilary Grabe; Mark W Johnson; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-12

8.  Bacterial endophthalmitis following 25-gauge transconjunctival sutureless vitrectomy.

Authors:  Drew N Sommerville; Dean P Hainsworth
Journal:  Clin Ophthalmol       Date:  2008-12

9.  Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection.

Authors:  Tansu Erakgun; Sait Egrilmez
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

10.  Differences between the combination of the 25-gauge vitrectomy with phacoemulsification versus 20-gauge vitrectomy and phacofragmentation.

Authors:  Pere Romero-Aroca; Matias Almena-Garcia; Marc Baget-Bernaldiz; Juan Fernández-Ballart; Isabel Méndez-Marin; Angel Bautista-Perez
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.